Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fengcai Zhu and Hantao Shu.
Fengcai Zhu
Connection Strength
0.117
Hantao Shu
  1. An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. Signal Transduct Target Ther. 2021 04 24; 6(1):165.
    View in: PubMed
    Score: 0.059
  2. Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2. Protein Cell. 2021 09; 12(9):734-740.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.